HEMATOLOGIC CANCER

Clinical trials for HEMATOLOGIC CANCER explained in plain language.

Never miss a new study

Get alerted when new HEMATOLOGIC CANCER trials appear

Sign up with your email to follow new studies for HEMATOLOGIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 8 Not yet recruiting 3 Not yet finished but already full! 1 Completed 1

New drug ABBV-101 targets Hard-to-Treat blood cancers in first human trial

Disease control Ongoing

This study tests a new experimental drug called ABBV-101 in adults with certain types of blood cancers (like lymphoma and leukemia) that have returned or not responded to prior treatments. The main goals are to check the drug's safety and find the best dose. About 340 participant…

Matched conditions: HEMATOLOGIC CANCER

Phase: PHASE1 • Sponsor: AbbVie • Aim: Disease control

Last updated May 17, 2026 00:47 UTC

HEMATOLOGIC CANCER

Get alerted when new HEMATOLOGIC CANCER trials appear

New drug ABBV-101 targets Hard-to-Treat blood cancers in first human trial